Enhanced Recovery and Biological Evaluation of Steviol Glycosides from Genotypically Diverse Stevia Rebaudiana
Annals of African Medicine · 2026
DOI: 10.4103/aam.aam_458_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of African Medicine, 2026. Verfasst von Taha Ouriagli und 5 weiteren Autor:innen. Beteiligte Einrichtung: URL CNRST N15, Laboratory of Human Pathology, Biomedicine and Environment, Department of Physiology, Faculty of Medicine, Pharmacy and Dentistry, Sid…. Hauptthemen laut MEDLINE: Stevia, Diterpenes, Kaurane, Antioxidants, Anti-Inflammatory Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Steviol glycosides (SGs) from Stevia rebaudiana are known for their natural sweetness and potential health benefits. However, extraction efficiency and biological activity vary across genotypes and depend on the extraction conditions. Aims and Objectives: This study aimed to evaluate the effect of an optimized extraction method on yield, total polyphenol content, and the in vitro antioxidant and anti-inflammatory activities of steviol glycosides obtained from six S. rebaudiana genotypes. Materials and Methods: Steviol glycosides were extracted using an optimized protocol. Extraction yield was quantified, and total polyphenol content was determined by the Folin–Ciocalteu method. Antioxidant activity was evaluated by the 2,2 diphenyl 1 picrylhydrazyl (DPPH) radical scavenging and reducing power assays, while anti-inflammatory potential was assessed by the protein denaturation inhibition method. Gallic acid, ascorbic acid and diclofenac sodium served as reference compounds.
Results
The optimized method significantly enhanced extraction efficiency, reaching 149.00 ± 1.76 mg/g and 142.20 ± 1.62 mg/g for genotypes P7 and V9 7/7, respectively. Genotypes P7, V9, and P7 7/7 exhibited the highest total polyphenol content (0.1 mg/mL). The most potent antioxidant activity was recorded for P7 7/7 and Q1 (DPPH IC 50 = 0.11 mg/mL), comparable to ascorbic acid (0.10 mg/mL). These genotypes also demonstrated the strongest anti-inflammatory activity (IC 50 = 53.77 and 66.06 µg/mL), close to diclofenac sodium (66.02 µg/mL).
Conclusion
The optimized extraction process substantially improves the yield and bioactivity of Stevia -derived compounds. Genotype P7 is notable for its high yield and polyphenol content, while P7 7/7 and Q1 show superior antioxidant and anti-inflammatory potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- URL CNRST N15, Laboratory of Human Pathology, Biomedicine and Environment, Department of Physiology, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
- Department of Biology, Laboratory of Functional Ecology and Engineering Environment, Faculty of Sciences and Techniques, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
- Department of Chemistry, Laboratory of Applied Organic Chemistry, Faculty of Sciences and Techniques, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
- Laboratory of Sciences, Care and Health Techniques, Higher Institute of Nursing Professions and Health Techniques, Meknes, Morocco.
Zitieren
APA
Ouriagli, T., Amnay, A., Raoui, S. M., Chahdi, F. O., Rodi, Y. K., & Chabir, R. (2026). Enhanced Recovery and Biological Evaluation of Steviol Glycosides from Genotypically Diverse Stevia Rebaudiana. Annals of African Medicine. https://doi.org/10.4103/aam.aam_458_25
Vancouver
Ouriagli T, Amnay A, Raoui SM, Chahdi FO, Rodi YK, Chabir R. Enhanced Recovery and Biological Evaluation of Steviol Glycosides from Genotypically Diverse Stevia Rebaudiana. Annals of African Medicine. 2026. doi:10.4103/aam.aam_458_25
BibTeX
@article{Ouriagli2026,
author = {Ouriagli, Taha and Amnay, Abdellatif and Raoui, Sidi Mohammed and Chahdi, Fouad Ouazzani and Rodi, Youssef Kandri and Chabir, Rachida},
title = {Enhanced Recovery and Biological Evaluation of Steviol Glycosides from Genotypically Diverse Stevia Rebaudiana},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_458_25}
}
EUVIMED